Welcome
Support Centre
07 August 2008 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
UKCCCR trial to study the effect on breast cancer mortality of annual mammographic screening starting at age 40
ISRCTN ISRCTN24647151
ClinicalTrials.gov identifier
Public title UKCCCR trial to study the effect on breast cancer mortality of annual mammographic screening starting at age 40
Scientific title
Acronym The 'Age' trial
Serial number at source G9000793
Study hypothesis To determine the effectiveness of mammographic screening starting at age 40, compared with starting at age 50, in reducing mortality from breast cancer.
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Breast cancer
Participants - inclusion criteria Women aged 40-41 identified from HA registers
Participants - exclusion criteria Women under care for breast cancer may be removed from the prior notification list by the GPs prior to randomisation
Anticipated start date 30/07/1990
Anticipated end date 31/12/2010
Status of trial Ongoing
Patient information material
Target number of participants 160,000
Interventions Women in the intervention group are offered annual screening by mammography until the year of their 48th birthday. Screening is by 2-view mammography at 1st screen and single view subsequently. All women in both intervention and control groups will be invited for screening in the NHSBSP between the age of 50-52.
Primary outcome measure(s) Deaths from breast cancer in women free of the disease at trial entry in the two groups. Information on prognostic factors of all breast cancers is also collected.
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Medical Research Council (UK)
Trial website
Publications Results: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=17161727

Protocol: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids= 10572845

Results: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids= 11979379
Contact name Dr  SM  Moss
  Address Cancer Screening Evaluation Unit
Institute of Cancer Research
Section of Epidemiology
D Block Cotswold Road
  City/town Sutton Surrey
  Zip/Postcode SM2 5NG
  Country United Kingdom
  Email
Sponsor Medical Research Council (UK)
  Address 20 Park Crescent
  City/town London
  Zip/Postcode W1B 1AL
  Country United Kingdom
  Tel +44 (0)20 7636 5422
  Fax +44 (0)20 7436 6179
  Email clinical.trial@headoffice.mrc.ac.uk
  Sponsor website: http://www.mrc.ac.uk
Date applied 06/04/2000
Last edited 07/02/2007
Date ISRCTN assigned 06/04/2000
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central